Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke

NCT00005883 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2011-03-28

No results posted yet for this study

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Phenethyl isothiocyanate may be effective in preventing lung cancer in smokers.

PURPOSE: Phase I trial of phenethyl isothiocyanate in preventing lung cancer in people who smoke.

Conditions

Interventions

DRUG

phenethyl isothiocyanate

Sponsors & Collaborators

Principal Investigators

  • Leonard Liebes, PhD · NYU Langone Health

Study Design

Purpose
PREVENTION

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2001-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005883 on ClinicalTrials.gov